Novartis and Roche win appeal against collective abuse fines

A French appellate court has quashed €444 million in fines levied by the country’s antitrust watchdog against Novartis and Roche, ruling that the drugmakers did not abuse their collective dominance by discouraging off-label prescriptions for a cheaper medicine.

Unlock unlimited access to all Global Competition Review content